Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen Carriers

Overview

Journal J Funct Biomater

Specialty Biomedical Engineering

Date 2017 Mar 25

PMID 28335469

Citations 11

Authors

Kazuaki Taguchi

Keishi Yamasaki

Toru Maruyama

Masaki Otagiri

Affiliations

Soon will be listed here.

Abstract

Hemoglobin (Hb) is an ideal material for use in the development of an oxygen carrier in view of its innate biological properties. However, the vascular retention of free Hb is too short to permit a full therapeutic effect because Hb is rapidly cleared from the kidney via glomerular filtration or from the liver via the haptogloblin-CD 163 pathway when free Hb is administered in the blood circulation. Attempts have been made to develop alternate acellular and cellular types of Hb based oxygen carriers (HBOCs), in which Hb is processed via various routes in order to regulate its pharmacokinetic properties. These HBOCs have been demonstrated to have superior pharmacokinetic properties including a longer half-life than the Hb molecule in preclinical and clinical trials. The present review summarizes and compares the pharmacokinetic properties of acellular and cellular type HBOCs that have been developed through different approaches, such as polymerization, PEGylation, cross-linking, and encapsulation.

Citing Articles

Therapeutic delivery of oxygen using artificial oxygen carriers demonstrates the possibility of treating a wide range of diseases.

Mohanto N, Mondal H, Park Y, Jee J J Nanobiotechnology. 2025; 23(1):25.

PMID: 39827150 PMC: 11742488. DOI: 10.1186/s12951-024-03060-9.

Artificial blood-hope and the challenges to combat tumor hypoxia for anti-cancer therapy.

Sharma R, Kashyap M, Zayed H, Krishnia L, Kashyap M Med Biol Eng Comput. 2024; .

PMID: 39614063 DOI: 10.1007/s11517-024-03233-6.

Hemoglobin nanoclusters-mediated regulation of KPNA4 in hypoxic tumor microenvironment enhances photodynamic therapy in hepatocellular carcinoma.

Wang Y, Li N, Qu L, Zhang M, Li Z, Li X J Nanobiotechnology. 2024; 22(1):473.

PMID: 39135024 PMC: 11318167. DOI: 10.1186/s12951-024-02717-9.

Hydrodynamic and thermodynamic analysis of PEGylated human serum albumin.

Correia J, Stafford W, Erlandsen H, Cole J, Premathilaka S, Isailovic D Biophys J. 2024; 123(16):2506-2521.

PMID: 38898654 PMC: 11365110. DOI: 10.1016/j.bpj.2024.06.015.

Development of novel polymer haemoglobin based particles as an antioxidant, antibacterial and an oxygen carrier agents.

Majid M, Ullah H, Alshehri A, Tabassum R, Aleem A, Khan A Sci Rep. 2024; 14(1):3031.

PMID: 38321082 PMC: 10847508. DOI: 10.1038/s41598-024-53548-5.

References

Nagao S, Taguchi K, Sakai H, Yamasaki K, Watanabe H, Otagiri M . Carbon monoxide-bound hemoglobin vesicles ameliorate multiorgan injuries induced by severe acute pancreatitis in mice by their anti-inflammatory and antioxidant properties. Int J Nanomedicine. 2016; 11:5611-5620. PMC: 5089833. DOI: 10.2147/IJN.S118185. View

Looker D, Cozart P, Durfee S, Hoffman S, Mathews A, Shoemaker S . A human recombinant haemoglobin designed for use as a blood substitute. Nature. 1992; 356(6366):258-60. DOI: 10.1038/356258a0. View

dAlmeida M, Sibbald W, White M, Chin-Yee I . Influence of sepsis on the plasma elimination pharmacokinetics of diaspirin crosslinked hemoglobin in rats. Artif Cells Blood Substit Immobil Biotechnol. 1998; 26(3):273-84. DOI: 10.3109/10731199809117458. View

Conover C, Gilbert C, Shum K, Shorr R . The impact of polyethylene glycol conjugation on bovine hemoglobin's circulatory half-life and renal effects in a rabbit top-loaded transfusion model. Artif Organs. 1997; 21(8):907-15. DOI: 10.1111/j.1525-1594.1997.tb00250.x. View

Schallner N, Pandit R, LeBlanc 3rd R, Thomas A, Ogilvy C, Zuckerbraun B . Microglia regulate blood clearance in subarachnoid hemorrhage by heme oxygenase-1. J Clin Invest. 2015; 125(7):2609-25. PMC: 4563677. DOI: 10.1172/JCI78443. View

Hughes Jr G, Francome S, Antal E, Adams W, Locker P, Yancey E . Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects. J Lab Clin Med. 1995; 126(5):444-51. View

Matheson B, Kwansa H, Bucci E, Rebel A, Koehler R . Vascular response to infusions of a nonextravasating hemoglobin polymer. J Appl Physiol (1985). 2002; 93(4):1479-86. DOI: 10.1152/japplphysiol.00191.2002. View

Usuba A, Osuka F, Sato R, Ogata Y, Gotoh H, Kimura T . Effect of liposome-encapsulated hemoglobin, neo red cells, on hemorrhagic shock. Surg Today. 1998; 28(10):1027-35. DOI: 10.1007/BF02483956. View

Mullah S, Abutarboush R, Moon-Massat P, Saha B, Haque A, Walker P . Sanguinate's effect on pial arterioles in healthy rats and cerebral oxygen tension after controlled cortical impact. Microvasc Res. 2016; 107:83-90. DOI: 10.1016/j.mvr.2016.06.001. View

10.

Conover C, Lejeune L, Shum K, Gilbert C, Shorr R . Physiological effect of polyethylene glycol conjugation on stroma-free bovine hemoglobin in the conscious dog after partial exchange transfusion. Artif Organs. 1997; 21(5):369-78. DOI: 10.1111/j.1525-1594.1997.tb00733.x. View

11.

Scatena R, Giardina B . O-raffinose-polymerised haemoglobin. A biochemical and pharmacological profile of an oxygen carrier. Expert Opin Biol Ther. 2001; 1(1):121-7. DOI: 10.1517/14712598.1.1.121. View

12.

Vandegriff K, Young M, Lohman J, Bellelli A, Samaja M, Malavalli A . CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats. Br J Pharmacol. 2008; 154(8):1649-61. PMC: 2518471. DOI: 10.1038/bjp.2008.219. View

13.

Van Der Plas J, Bleeker W, van Hamersveld A, Rigter G, LOOS J, BAKKER J . Oxygen affinity of hemoglobin solutions modified by coupling with NFPLP and the effects on tissue oxygenation in the isolated perfused rat liver. Adv Exp Med Biol. 1985; 191:473-83. DOI: 10.1007/978-1-4684-3291-6_48. View

14.

Vandegriff K, Winslow R . Hemospan: design principles for a new class of oxygen therapeutic. Artif Organs. 2009; 33(2):133-8. DOI: 10.1111/j.1525-1594.2008.00697.x. View

15.

Misra H, Bainbridge J, Berryman J, Abuchowski A, Galvez K, Uribe L . A Phase Ib open label, randomized, safety study of SANGUINATE™ in patients with sickle cell anemia. Rev Bras Hematol Hemoter. 2017; 39(1):20-27. PMC: 5339363. DOI: 10.1016/j.bjhh.2016.08.004. View

16.

Taguchi K, Miyasato M, Ujihira H, Watanabe H, Kadowaki D, Sakai H . Hepatically-metabolized and -excreted artificial oxygen carrier, hemoglobin vesicles, can be safely used under conditions of hepatic impairment. Toxicol Appl Pharmacol. 2010; 248(3):234-41. DOI: 10.1016/j.taap.2010.08.006. View

17.

Tokuno M, Taguchi K, Yamasaki K, Sakai H, Otagiri M . Long-Term Stored Hemoglobin-Vesicles, a Cellular Type of Hemoglobin-Based Oxygen Carrier, Has Resuscitative Effects Comparable to That for Fresh Red Blood Cells in a Rat Model with Massive Hemorrhage without Post-Transfusion Lung Injury. PLoS One. 2016; 11(10):e0165557. PMC: 5087860. DOI: 10.1371/journal.pone.0165557. View

18.

Taguchi K, Maruyama T, Otagiri M . Pharmacokinetic properties of hemoglobin vesicles as a substitute for red blood cells. Drug Metab Rev. 2011; 43(3):362-73. DOI: 10.3109/03602532.2011.558094. View

19.

Nagao S, Taguchi K, Sakai H, Tanaka R, Horinouchi H, Watanabe H . Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced pulmonary fibrosis. Biomaterials. 2014; 35(24):6553-62. DOI: 10.1016/j.biomaterials.2014.04.049. View

20.

Njoku M, St Peter D, Mackenzie C . Haemoglobin-based oxygen carriers: indications and future applications. Br J Hosp Med (Lond). 2015; 76(2):78-83. DOI: 10.12968/hmed.2015.76.2.78. View